Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma

• Material Type: 博士論文
• Title: Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma
• Author/Editor: Oura, Masahiro; Harada, Takeshi; Oda, Asuka; Teramachi, Jumpei; Nakayama, Atsushi; Sumitani, Ryohei; Inoue, Yusuke; Maeda, Yusaku; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Nakamura, Masafumi; Hara, Tomoyo; Yamagami, Hiroki; Kurahashi, Kiyoe; Endo, Itsuro; Hasegawa, Hiroo; Fujiwara, Hiroshi; Abe, Masahiro
• Author Heading: Oura, Masahiro; Harada, Takeshi; Oda, Asuka; Teramachi, Jumpei; Nakayama, Atsushi; Sumitani, Ryohei; Inoue, Yusuke; Maeda, Yusaku; Sogabe, Kimiko; Maruhashi, Tomoko; Takahashi, Mamiko; Fujii, Shiro; Nakamura, Shingen; Miki, Hirokazu; Nakamura, Masafumi; Hara, Tomoyo; Yamagami, Hiroki; Kurahashi, Kiyoe; Endo, Itsuro; Hasegawa, Hiroo; Fujiwara, Hiroshi; Abe, Masahiro
• Publication, Distribution, etc.: British Society for Haematology|John Wiley & Sons
• Publication Date: 2023-07-27
• Publication Date (W3CDTF): 2023-07-27
• Alternative Title: レゾルシル酸ラクトンLL-Z1640-2の成人T細胞白血病/リンパ腫に対する治療効果
• Degree grantor/type: 徳島大学
• Date Granted: 2023-10-26
• Date Granted (W3CDTF): 2023-10-26
• Dissertation Number: 甲第3759号
• Degree Type: 博士（医学）
• Text Language Code: eng
• Subject Heading: ATL; HTLV-1; IRF4; NF-κB; TAK1
• Target Audience: 一般
• Note (General): Adult T-cell leukaemia/lymphoma (ATL) remains incurable. The NF-κB and interferon regulatory factor 4 (IRF4) signalling pathways are among the critical survival pathways for the progression of ATL. TGF-β-activated kinase 1 (TAK1), an IκB kinase-activating kinase, triggers the activation of NF-κB. The resorcylic acid lactone LL-Z1640-2 is a potent irreversible inhibitor of TAK1/extracellular signal-regulated kinase 2 (ERK2). We herein examined the therapeutic efficacy of LL-Z1640-2 against ATL. LL-Z1640-2 effectively suppressed the in vivo growth of ATL cells. It induced in vitro apoptosis and inhibited the nuclear translocation of p65/RelA in ATL cells. The knockdown of IRF4 strongly induced ATL cell death while downregulating MYC. LL-Z1640-2 as well as the NF-κB inhibitor BAY11-7082 decreased the expression of IRF4 and MYC at the protein and mRNA levels, indicating the suppression of the NF-κB-IRF4-MYC axis. The treatment with LL-Z1640-2 also mitigated the phosphorylation of p38 MAPK along with the expression of CC chemokine receptor 4. Furthermore, the inhibition of STAT3/5 potentiated the cytotoxic activity of LL-Z1640-2 against IL-2-responsive ATL cells in the presence of IL-2. Therefore, LL-Z1640-2 appears to be an effective treatment for ATL. Further studies are needed to develop more potent compounds that retain the active motifs of LL-Z1640-2.
• Persistent ID (NDL): info:ndljp/pid/13122513; https://dl.ndl.go.jp/pid/13122513
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2023-12-15T22:13:24+09:00
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://repo.lib.tokushima-u.ac.jp/118740
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp